[en] Two 4-ethyl-substituted pyridothiadiazine dioxides belonging to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor positive allosteric modulators were cocrystallized with the GluA2 ligand binding domain in order to decipher the impact of the position of the nitrogen atom on their binding mode at the AMPA receptors. The latter was found to be very similar to that of previously described benzothiadiazine-type AMPA receptor modulators. The affinity of the two compounds for the receptor was determined by isothermal titration calorimetry. Accordingly, the synthesis and biological evaluation of novel 4-cyclopropyl-substituted pyridothiadiazine dioxides was performed and completed with the synthesis of the corresponding chloro-substituted 4-cyclopropyl-3,4-dihydro-2H-benzothiadiazine 1,1-dioxides. The “8-aza” compound 32 was found to be the most potent pyridothiadiazine-type AMPA receptor potentiator in vitro, whereas the 7-chloro-substituted compound 36c emerged as the most promising benzothiadiazine dioxide. Due to proper drug-likeness and low in vivo acute toxicity in mice, 36c was chosen for a more complete preclinical evaluation. The compound was able to easily cross the blood–brain barrier. In an in vivo object recognition test with CD1 mice, oral administration of 36c was found to significantly improve cognition performance at doses as low as 1 mg/kg.
Disciplines :
Pharmacy, pharmacology & toxicology Chemistry
Author, co-author :
Francotte, Pierre ✱; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Nørholm, Ann-Beth ✱
Deva, Taru
Olsen, Lars
Frydenvang, Karla
Goffin, Eric ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Fraikin, Pierre
De Tullio, Pascal ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Challal, Sylvie
Thomas, Jean-Yves
Iop, Fabrice
Louis, Caroline
Botez-Pop, Iuliana
Lestage, Pierre
Danober, Laurence
Kastrup, Jette S. ✱
Pirotte, Bernard ✱; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Francotte, P.; de Tullio, P.; Fraikin, P.; Counerotte, S.; Goffin, E.; Pirotte, B. In search of novel AMPA potentiators Recent Pat. CNS Drug Discovery 2006, 1, 239-246
Staubli, U.; Rogers, G.; Lynch, G. Facilitation of glutamate receptors enhances memory Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 777-781
Palmer, C. L.; Cotton, L.; Henley, J. M. The molecular pharmacology and cell biology of R -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors Pharmacol. Rev. 2005, 57, 253-277
Mansour, M.; Nagarajan, N.; Nehring, R. B.; Clements, J. D.; Rosenmund, C. Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement Neuron 2001, 32, 841-853
Robert, A.; Irizarry, S. N.; Hughes, T. E.; Howe, J. R. Subunit interactions and AMPA receptor desensitization J. Neurosci. 2001, 21, 5574-5586
Greger, I. H.; Esteban, J. A. AMPA receptor biogenesis and trafficking Curr. Opin. Neurobiol. 2007, 17, 289-297
Armstrong, N.; Gouaux, E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core Neuron 2000, 28, 165-181
Gouaux, E. Structure and function of AMPA receptors J. Physiol. 2004, 554, 249-253
Collingridge, G. L.; Isaac, J. T.; Wang, Y. T. Receptor trafficking and synaptic plasticity Nature Rev. Neurosci. 2004, 5, 952-962
Pirotte, B.; Francotte, P.; Goffin, E.; de Tullio, P. AMPA receptor positive allosteric modulators: A patent review Expert Opin. Ther. Pat. 2013, 23, 615-628
Pirotte, B.; Francotte, P.; Goffin, E.; Fraikin, P.; Danober, L.; Lesur, B.; Botez, I.; Caignard, D.-H.; Lestage, P.; de Tullio, P. Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators Curr. Med. Chem. 2010, 17, 3575-3582
Dicou, E.; Rangon, C. M.; Guimiot, F.; Spedding, M.; Gressens, P. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain Brain Res. 2003, 970, 221-225
Zarate, C. A., Jr.; Manji, H. K. The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases Exp. Neurol. 2008, 211, 7-10
Alt, A.; Nisenbaum, E. S.; Bleakman, D.; Witkin, J. M. A role for AMPA receptors in mood disorders Biochem. Pharmacol. 2006, 71, 1273-1288
Goff, D. C.; Leahy, L.; Berman, I.; Posever, T.; Herz, L.; Leon, A. C.; Johnson, S. A.; Lynch, G. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia J. Clin. Psychopharmacol. 2001, 21, 484-487
Lynch, G. AMPA receptor modulators as cognitive enhancers Curr. Opin. Pharmacol. 2004, 4, 4-11
Sanacora, G.; Zarate, C. A.; Krystal, J. H.; Manji, H. K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat. Rev. Drug Discovery 2008, 7, 426-437
Adler, L. A.; Kroon, R. A.; Stein, M.; Shahid, M.; Tarazi, F. I.; Szegedi, A.; Schipper, J.; Cazorla, P. A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator Org 26576 in adult attention-deficit/hyperactivity disorder Biol. Psychiatry 2012, 72, 971-977
Siegel, G. J.; Chauhan, N. B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain Brain Res. Rev. 2000, 33, 199-227
Lauterborn, J. C.; Lynch, G.; Vanderklish, P.; Arai, A.; Gall, C. M. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons J. Neurosci. 2000, 20, 8-21
Lauterborn, J. C.; Truong, G. S.; Baudry, M.; Bi, X.; Lynch, G.; Gall, C. M. Chronic elevation of brain-derived neurotrophic factor by ampakines J. Pharmacol. Exp. Ther. 2003, 307, 297-305
Lauterborn, J. C.; Pineda, E.; Chen, L. Y.; Ramirez, E. A.; Lynch, G.; Gall, C. M. Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression Neuroscience 2009, 159, 283-295
Yamada, K. A.; Rothman, S. M. Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons J. Physiol. 1992, 458, 409-423
Yamada, K. A.; Tang, C. M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents J. Neurosci. 1993, 13, 3904-3915
Bertolino, M.; Baraldi, M.; Parenti, C.; Braghiroli, D.; DiBella, M.; Vicini, S.; Costa, E. Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus Recept. Channels 1993, 1, 267-278
Zivkovic, I.; Thompson, D. M.; Bertolino, M.; Uzunov, D.; DiBella, M.; Costa, E.; Guidotti, A. 7-Chloro-3-methyl-3,4-dihydro-2 H -1,2,4-benzothiadiazine S, S -dioxide (IDRA 21): A benzothiadiazine derivative that enhances cognition by attenuating dl -alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization J. Pharmacol. Exp. Ther. 1995, 272, 300-309
Thompson, D. M.; Guidotti, A.; DiBella, M.; Costa, E. 7-Chloro-3-methyl-3,4-dihydro-2 H -1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 7667-7671
Pirotte, B.; Podona, T.; Diouf, O.; de Tullio, P.; Lebrun, P.; Dupont, L.; Somers, F.; Delarge, J.; Morain, P.; Lestage, P.; Lepagnol, J.; Spedding, M. 4 H -1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4 H -1,2,4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R / S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: Design, synthesis, pharmacology, and structure-activity relationships J. Med. Chem. 1998, 41, 2946-2959
Francotte, P.; de Tullio, P.; Goffin, E.; Dintilhac, G.; Graindorge, E.; Fraikin, P.; Lestage, P.; Danober, L.; Thomas, J.-Y.; Caignard, D.-H.; Pirotte, B. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2 H -1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors J. Med. Chem. 2007, 50, 3153-3157
Francotte, P.; de Tullio, P.; Podona, T.; Diouf, O.; Fraikin, P.; Lestage, P.; Danober, L.; Thomas, J.-Y.; Caignard, D.-H.; Pirotte, B. Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators Bioorg. Med. Chem. 2008, 16, 9948-9956
Francotte, P.; Goffin, E.; Fraikin, P.; Lestage, P.; Van Heugen, J.-C.; Gillotin, F.; Danober, L.; Thomas, J.-Y.; Chiap, P.; Caignard, D.-H.; Pirotte, B.; de Tullio, P. New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: Discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors J. Med. Chem. 2010, 53, 1700-1711
Nørholm, A. B.; Francotte, P.; Olsen, L.; Krintel, C.; Frydenvang, K.; Goffin, E.; Challal, S.; Danober, L.; Botez-Pop, I.; Lestage, P.; Pirotte, B.; Kastrup, J. S. Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2 H -1,2,4-benzothiadiazine 1,1-dioxide scaffold J. Med. Chem. 2013, 56, 8736-8745
Francotte, P.; Goffin, E.; Fraikin, P.; Graindorge, E.; Lestage, P.; Danober, L.; Challal, S.; Rogez, N.; Nosjean, O.; Caignard, D.-H.; Pirotte, B.; de Tullio, P. Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors J. Med. Chem. 2013, 56, 7838-7850
Krintel, C.; Frydenvang, K.; Olsen, L.; Kristensen, M. T.; de Barrios, O.; Naur, P.; Francotte, P.; Pirotte, B.; Gajhede, M.; Kastrup, J. S. Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2 Biochem. J. 2012, 441, 173-178
Ptak, C. P.; Ahmed, A. H.; Oswald, R. E. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives Biochemistry 2009, 48, 8594-8602
Weeks, A. M.; Harms, J. E.; Partin, K. M.; Benveniste, M. Functional insight into development of positive allosteric modulators of AMPA receptors Neuropharmacology 2014, 85, 57-66
Greger, I. H.; Akamine, P.; Khatri, L.; Ziff, E. B. Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis Neuron 2006, 51, 85-97
Meerwein, H.; Dittmar, G.; Gollner, R.; Hafner, K.; Mensch, F.; Steinfort, O. Aromatic diazo compounds. II. Preparation of aromatic sulfonyl chlorides, a new modification of the Sandmeyer reaction Chem. Ber. 1957, 90, 841-852
Cowen, M. S.; Beart, P. M. Cyclothiazide and AMPA receptor desensitization: Analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices Br. J. Pharmacol. 1998, 123, 473-480
Lockhart, B.; Iop, F.; Closier, M.; Lestage, P. (S)-2,3-Dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1), a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices Eur. J. Pharmacol. 2000, 401, 145-153
Roux, S.; Sablé, E.; Porsolt, R. D. Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effects on behavior and physiological function. Curr. Protoc. Pharmacol. 2005, Chapter 10, Unit 10.10.
Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A 'rule of three' for fragment-based lead discovery? Drug Discovery Today 2003, 8, 876-877
Qi, J.; Wang, Y.; Jiang, M.; Warren, P.; Chen, G. Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo J. Physiol. 2006, 571, 605-618
Bliss, T. V.; Collingridge, G. L. A synaptic model of memory: Long-term potentiation in the hippocampus Nature 1993, 361, 31-39
Whitlock, J. R.; Heynen, A. J.; Shuler, M. G.; Bear, M. F. Learning induces long-term potentiation in the hippocampus Science 2006, 313, 1093-1097
Ennaceur, A.; Delacour, J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data Behav. Brain Res. 1988, 31, 47-59
Winn, M. D.; Ballard, C. C.; Cowtan, K. D.; Dodson, E. J.; Emsley, P.; Evans, P. R.; Keegan, R. M.; Krissinel, E. B.; Leslie, A. G. W.; McCoy, A.; McNicholas, S. J.; Murshudov, G. N.; Pannu, N. S.; Potterton, E. A.; Powell, H. R.; Read, R. J.; Vagin, A.; Wilson, K. S. Overview of the CCP4 suite and current developments Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 235-242
McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser crystallographic software J. Appl. Crystallogr. 2007, 40, 658-674
Sun, Y.; Olson, R.; Horning, M.; Armstrong, N.; Mayer, M.; Gouaux, E. Mechanism of glutamate receptor desensitization Nature 2002, 417, 245-253
Langer, G.; Cohen, S. X.; Lamzin, V. S.; Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 Nat. Protoc. 2008, 3, 1171-1179
Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K. Features and development of Coot Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 486-501
Schuttelkopf, A. W.; van Aalten, D. M. F. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 1355-1363
Moriarty, N. W.; Grosse-Kunstleve, R. W.; Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): A tool for ligand coordinate and restraint generation Acta Crystallogr., Sect. D: Biol. Crystallogr. 2009, 65, 1074-1080
Adams, P. D.; Afonine, P. V.; Bunkóczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L.-W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. PHENIX: A comprehensive Python-based system for macromolecular structure solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221
Hayward, S.; Lee, R. A. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50 J. Mol. Graph. Model. 2002, 21, 181-183
Morisawa, Y.; Kataoka, M.; Nagahori, H.; Sakamoto, T.; Kitano, N.; Kusano, K.; Sato, K. Studies on anticoccidial agents. 13. Synthesis and anticoccidial activity of nitropyridine-2- and -3-sulfonamides and derivatives J. Med. Chem. 1980, 23, 1376-1380
Pirotte, B.; de Tullio, P.; Lebrun, P.; Antoine, M.-H.; Fontaine, J.; Masereel, B.; Schynts, M.; Dupont, L.; Herchuelz, A.; Delarge, J. 3-(Alkylamino)-4 H -pyrido[4,3- e ]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: A new class of potassium channel openers? J. Med. Chem. 1993, 36, 3211-3213
Albert, A.; Serjeant, E. P. The Determination of Ionization Constants; Chapman & Hall: London, 1971; pp 44-64.
Laskowski, R. A.; Macarthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK-A program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 1993, 26, 283-291
